CRANBURY, N.J., Feb. 6, 2015 /PRNewswire/ -- Palatin
Technologies, Inc. (NYSE MKT: PTN) announced that it will be
presenting at the 17th Annual BIO CEO & Investor
Conference. Hosted by the Biotechnology Industry Organization
(BIO), the 17th Annual BIO CEO & Investor Conference
will take place February 9-10 at the
Waldorf Astoria in New York
City.
Carl Spana, Ph.D., President and
Chief Executive Officer of Palatin Technologies, will provide an
update on Palatin's corporate and development programs on
Monday, February 9, 2015 at
1:30 p.m. ET.
About Palatin Technologies, Inc.
Palatin
Technologies, Inc. is a biopharmaceutical company developing
targeted, receptor-specific peptide therapeutics for the treatment
of diseases with significant unmet medical need and commercial
potential. Palatin's strategy is to develop products and then form
marketing collaborations with industry leaders in order to maximize
their commercial potential. For additional information regarding
Palatin, please visit Palatin's website at
http://www.palatin.com.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/palatin-technologies-to-present-at-the-bio-ceo--investor-conference-300032355.html
SOURCE Palatin Technologies, Inc.